R. S. Allen - Concepedia

Author

R. S. Allen

Also Known As

R Allen, R S Allen, R. Allen, R. S. ALLEN, R. S. Allen, R.S. Allen, Roberta Allen, Roberta S. Allen, Roberta Stauder Allen, Roberta. Allen

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Salk Institute for Biological Studies The University of Texas MD Anderson Cancer Center Sunesis (United States)University of Rochester

About

R. S. Allen is an author at Salk Institute for Biological Studies specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	702
2	Health Sciences	3	3	229
3	Biochemistry	2	2	33
4	Social Sciences	1	1	13
5	Biomedical Engineering	1	1	10

R. S. Allen

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial Gregory A. Wiseman, Leo I. Gordon, Pratik S. Multani, Blood	2002	266
The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors Changhai Cui, T. K. Booker, R. S. Allen, Journal of Neuroscience Dopaminergic TractsNeurotransmitterNeurotransmissionModulate Dopamine ReleaseSynaptic Signaling	2003	209
Bombesin-like activity: Radioimmunologic assessment in biological tissues Marvin R. Brown, R. S. Allen, Jose Villareal, Life Sciences BioanalysisImmunologyRadiopharmaceutical TherapyBombesin-like ActivityToxicology	1978	201
Elevation of plasma neuropeptide Y levels in congestive heart failure Alan S. Maisel, Neal A. Scott, Harvey Motulsky, The American Journal of Medicine Heart FailureCardiovascular DiseasePhysiologyNeurologyCongestive Heart Failure	1989	119
Voreloxin, a First-in-Class Anticancer Quinolone Derivative, in Relapsed/Refractory Solid Tumors: A Report on Two Dosing Schedules Ranjana H. Advani, Herbert I. Hurwitz, Michael S. Gordon, Clinical Cancer Research	2010	45
A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia Jeffrey E. Lancet, Farhad Ravandi, Rebecca M. Ricklis, Leukemia	2011	44
AQUEOUS EXTRACTS OF PANCREAS H. A. Piper, R. S. Allen, John R. Murlin Journal of Biological Chemistry NutritionPancreatic Fluid CollectionMedicineGastroenterologyPharmacology	1923	44
Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody Alice B. Gottlieb, Mark Lebwohl, Mark C. Totoritis, Journal of the American Academy of Dermatology Anti-cd80 Monoclonal AntibodyAutoimmune DiseaseMedicineImmunologySingle-dose Treatment	2002	40
Initial Trials of Anti-CD80 Monoclonal Antibody (Galiximab) Therapy for Patients with Relapsed or Refractory Follicular Lymphoma Anas Younes, Kandasamy Hariharan, R. S. Allen, Clinical Lymphoma Anti-cd80 Monoclonal AntibodyLymphoid NeoplasiaInitial TrialsMedicineMalignant Blood Disorder	2003	35
THE EFFECT OF ADDED CARRIER ON THE DISTRIBUTION AND EXCRETION OF SOLUBLE BE7 J.K. Scott, W.F. Neuman, R. S. Allen Journal of Biological Chemistry PharmacologyBiochemistry	1950	23

Page 1